Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | AKT2 | P31751 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.31 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15430281 | 0.89 | AKT1 (0.30) | AKT1AKT2 | |
| SCHEMBL15430265 | 0.89 | LIMK1 (0.36) | LIMK1 | |
| SCHEMBL15430274 | 0.86 | LIMK1 (0.31) | LIMK1 | |
| SCHEMBL15430248 | 0.83 | ALOX5 (0.44) | — | |
| SCHEMBL15430241 | 0.83 | ALOX5 (0.44) | — | |
| SCHEMBL15430246 | 0.82 | ALOX5 (0.43) | LIMK1 | |
| SCHEMBL15430268 | 0.82 | LIMK1 (0.32) | LIMK1 | |
| SCHEMBL15430349 | 0.81 | ALDH1A1 (0.39) | ABCG2SERPINE1 | |
| SCHEMBL15430249 | 0.81 | ALOX5 (0.40) | — | |
| SCHEMBL15430251 | 0.81 | ALOX5 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140014930-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-01-16 | — | — | US | disclosed |
| US-20140014930-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-01-16 | — | — | US | disclosed |
| US-20070037979-A1 | Preparation of rosuvastatin | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037979-A1 | Preparation of rosuvastatin | HMGCR, PCSK9, PCSK7 | AKT1 101/4885AKT2 215/4885TNKS 353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.